Dapaglow 10 Tablet
Marketer
Daxin Pharmaceutical Pvt Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Dapaglow 10 Tablet
Metformin 10mg tablets are indicated as monotherapy or in combination regimens to manage type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. Metformin 10mg can be administered with or without food, consistently at the same time daily, as directed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation may lead to hyperglycemia and potentially serious consequences such as renal impairment and vision loss. This medication forms part of a comprehensive diabetes management plan, incorporating dietary adjustments, physical activity, and weight management as recommended by your doctor. Commonly reported adverse effects include vaginal yeast infections, upper respiratory tract inflammation, and urinary tract infections. Dehydration may occur; increased fluid intake is recommended. Practicing good hygiene can reduce the likelihood of genital infections. Prior to commencing treatment, discuss any pre-existing renal or hepatic conditions, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption during treatment to minimize potential side effects. Regular blood glucose monitoring is essential during therapy.
Primary Ingredients of Dapaglow 10 Tablet
No information provided. Therefore, no rephrased text can be given.
Uses of Dapaglow 10 Tablet
Managing type 2 diabetes
Major Benefits of Dapaglow 10 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaglow 10 Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dapaglow 10 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaglow 10 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaglow 10 Tablet can be consumed with or without food; however, consistent daily timing is recommended.
How Dapaglow 10 Tablet works:
Dapagliflozin 10 mg tablets are used to manage diabetes. Their mechanism involves facilitating the excretion of excess glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Dapaglow 10 Tablet should not be taken together.
PregnancyCONSULT YOUR DOCTOR
Using Dapagliflozin 10 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Dapagliflozin 10 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should likely abstain from Dapaglow 10 Tablet due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapagliflozin 10 mg tablets are considered safe for use in individuals with hepatic impairment. No alteration to the Dapagliflozin 10 mg tablet dosage is necessary.
What if you forget to take Dapaglow 10 Tablet :
Should you forget a Dapaglow 10 Tablet dose, take it immediately if possible. Otherwise, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapaglow 10 Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently